Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-1-12
pubmed:abstractText
HT-29 sublines and Caco-2 clones were analyzed for the expression of cytochrome P-450 3A. The enzyme was found to be expressed in differentiated HT-29 cells selected by resistance to methotrexate and in one of seven Caco-2 clones, TC7. Its expression parallels the differentiation process, with highest levels being observed at late confluency. P-450 3A mRNA and protein patterns, as well as subcellular distribution, are intermediate between those observed in human adult intestine and fetal liver.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0014-5793
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
355
pubmed:geneSymbol
CYP3A
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
247-50
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:7988682-Blotting, Northern, pubmed-meshheading:7988682-Blotting, Western, pubmed-meshheading:7988682-Carcinoma, pubmed-meshheading:7988682-Cell Compartmentation, pubmed-meshheading:7988682-Cell Differentiation, pubmed-meshheading:7988682-Clone Cells, pubmed-meshheading:7988682-Colonic Neoplasms, pubmed-meshheading:7988682-Cytochrome P-450 CYP2E1, pubmed-meshheading:7988682-Cytochrome P-450 Enzyme System, pubmed-meshheading:7988682-Drug Resistance, pubmed-meshheading:7988682-Fluorescent Antibody Technique, pubmed-meshheading:7988682-Gene Expression Regulation, Neoplastic, pubmed-meshheading:7988682-Humans, pubmed-meshheading:7988682-Methotrexate, pubmed-meshheading:7988682-Mixed Function Oxygenases, pubmed-meshheading:7988682-RNA, Messenger, pubmed-meshheading:7988682-Selection, Genetic, pubmed-meshheading:7988682-Tumor Cells, Cultured
pubmed:year
1994
pubmed:articleTitle
Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7.
pubmed:affiliation
Unité de Recherches de Biochimie Pharmacologique et Métabolique (INSERM U75), Centre Hospitalo-Universitaire Necker-Enfants Malades, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't